Department of Gynecological Oncology, Chongqing Cancer Institute/Hospital, 181 Hanyu Lane, Shapingba District, Chongqing 400030, People's Republic of China.
Arch Gynecol Obstet. 2012 Jun;285(6):1627-32. doi: 10.1007/s00404-011-2203-4. Epub 2012 Jan 6.
Via a large population-based survey conducted in rural, southwestern China, we aim to evaluate the effect of visual inspection with acetic acid/Lugol's iodine (VIA/VILI) on diagnosing cases of cervical cancer and of pre-cancerous lesions while exploring the mode of cervical prevention and control in low-resource settings in China.
Women aged 30-59 years from Chongqing, China were recruited from 2006 to 2009. Participants underwent VIA/VILI, and, if positive, received colposcopy-directed or random biopsies. Women with negative VIA/VILI or biopsy-confirmed cervical intraepithelial neoplasia (CIN) 1 lesions diagnosed in the first round of screening were re-screened in the following year with the same procedure.
In total, 10,269 women received VIA/VILI. The average age of participants was 40.9 ± 7.6 years. Overall, 0.85% (87/10,269) of women were diagnosed via pathology-confirmed biopsy with CIN1, 0.25% (26/10,269) with CIN2, 0.27% (28/10,269) with CIN3, and 0.02% (2/10,269) with cervical cancer. Over half (57.7%) of CIN2 lesions, the majority of CIN3 lesions (89.3%), and all cancer cases (100%) were detected in the first round of screening.
In a rural, low-resource setting in China, one-time VIA/VILI screening detected more than a half of CIN2 cases, most CIN3 cases and all the cervical cancer cases. Detection rates of CIN2 lesions significantly increased with a 1-year follow-up VIA/VILI screen. Therefore, if multiple cervical cancer screenings are not feasible logistically or financially, a one-time VIA/VILI may be the most efficient strategy to detect cervical cancer and most CIN3 lesions in women in low-resource settings.
通过在中国西南部农村进行的一项大型人群调查,我们旨在评估醋酸/卢戈氏碘目视检查(VIA/VILI)对诊断宫颈癌和癌前病变病例的效果,同时探索在中国资源匮乏环境下的宫颈癌防控模式。
2006 年至 2009 年,我们从中国重庆招募了年龄在 30-59 岁的女性。参与者接受了 VIA/VILI 检查,如果结果阳性,则接受阴道镜引导下或随机活检。在第一轮筛查中,VIA/VILI 阴性或活检证实为宫颈上皮内瘤变(CIN)1 病变的女性,如果在第一轮筛查中被诊断为 CIN1 病变,则在次年用相同的程序进行再次筛查。
共有 10269 名女性接受了 VIA/VILI 检查。参与者的平均年龄为 40.9±7.6 岁。总的来说,通过病理证实的活检,0.85%(87/10269)的女性被诊断为 CIN1,0.25%(26/10269)为 CIN2,0.27%(28/10269)为 CIN3,0.02%(2/10269)为宫颈癌。超过一半(57.7%)的 CIN2 病变、绝大多数(89.3%)的 CIN3 病变和所有(100%)的癌症病例都在第一轮筛查中被发现。
在中国农村资源匮乏的环境下,一次性 VIA/VILI 筛查发现了超过一半的 CIN2 病例、大多数 CIN3 病例和所有宫颈癌病例。在进行为期 1 年的 VIA/VILI 随访筛查后,CIN2 病变的检出率显著增加。因此,如果在后勤或财务上不可能进行多次宫颈癌筛查,那么一次性 VIA/VILI 可能是在资源匮乏环境下检测宫颈癌和大多数 CIN3 病变的最有效策略。